China Longevity Group Co Ltd

China Longevity Group Co Ltd has a basic capital structure with no dilution risk, as the number of basic and diluted shares outstanding is identical at 852,612,470. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

The company's profitability is reflected in its last actual EPS of 0.40 CNY and revenue of 1,197,085,000 CNY. While these figures provide a baseline, they must be compared to the industry's preferred metrics and cohort medians to determine relative performance. The valuation snapshot is currently empty, so no direct comparison to industry benchmarks is available at this time.

The company's revenue is concentrated in a single business segment, as disclosed in its profile, with no geographic breakdown provided in the available data. This lack of diversification may expose the company to higher operational and market risks.

The company's growth trajectory is not quantified in the available data, as the outlook for the current and next fiscal years is not provided. Analysts have recorded the last actual revenue and EPS, but forward-looking guidance is absent.

The risk assessment indicates low dilution potential, with no near-term dilution pressure identified. However, the absence of liquidity data and the lack of a valuation snapshot limit the ability to fully assess financial health.

No recent events, such as filings or transcripts, are available in the provided data to inform the company's current strategic or operational direction.

Revenue ¥1.21B, +3,4% YoY; Operating income −2,9% YoY.

• ▍Revenue ¥1.21B, +3,4% YoY
• ▍Operating income −2,9% YoY
• ▍Net income −20,2% YoY
• ▍Free cash flow +83,4% YoY
• ▍Net margin 3.7%

Revenue ¥1.17B, +24,8% YoY; Operating income −1,6% YoY.

• ▍Revenue ¥1.17B, +24,8% YoY
• ▍Operating income −1,6% YoY
• ▍Net income −11,8% YoY
• ▍Free cash flow +92,7% YoY
• ▍Net margin 4.8%